Paper26418745
FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.
Guan J and 12 others. Elife, 2015. Cited by 117 papers, by iCite.
Cite this record
ConductScience Library. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase. Papers, record 26418745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26418745
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytokines | Major topic |
| Enzyme Activation | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Anaplastic Lymphoma Kinase | |
| Cell Line | |
| Humans | |
| Molecular Sequence Data | |
| Protein Binding | |
| Sequence Analysis, DNA |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12062106 | HEN-1, a secretory protein with an LDL receptor motif, regulates sensory integration and learning in Caenorhabditis elegans. | Cell | 2002 | https://conductscience.org/library/papers/12062106 | PubMed |
| 2 | 8223268 | Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. | Development | 1993 | https://conductscience.org/library/papers/8223268 | PubMed |
| 3 | 25605972 | Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK. | Sci Signal | 2015 | https://conductscience.org/library/papers/25605972 | PubMed |
| 4 | 18923524 | Oncogenic mutations of ALK kinase in neuroblastoma. | Nature | 2008 | https://conductscience.org/library/papers/18923524 | PubMed |
| 5 | 17285636 | The ligand Jelly Belly (Jeb) activates the Drosophila Alk RTK to drive PC12 cell differentiation, but is unable to activate the mouse ALK RTK. | J Exp Zool B Mol Dev Evol | 2007 | https://conductscience.org/library/papers/17285636 | PubMed |
| 6 | 15886198 | Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin. | J Biol Chem | 2005 | https://conductscience.org/library/papers/15886198 | PubMed |
| 7 | 25955180 | Targeted Disruption of ALK Reveals a Potential Role in Hypogonadotropic Hypogonadism. | PLoS One | 2015 | https://conductscience.org/library/papers/25955180 | PubMed |
| 8 | 25331893 | Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25331893 | PubMed |
| 9 | 23104988 | Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma. | Dis Model Mech | 2013 | https://conductscience.org/library/papers/23104988 | PubMed |
| 10 | 25351247 | The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma. | Sci Signal | 2014 | https://conductscience.org/library/papers/25351247 | PubMed |
| 11 | 20190816 | Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells. | Oncogene | 2010 | https://conductscience.org/library/papers/20190816 | PubMed |
| 12 | 22079349 | Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis. | Pharmacol Biochem Behav | 2012 | https://conductscience.org/library/papers/22079349 | PubMed |
| 13 | 17586306 | Neuroblastoma. | Lancet | 2007 | https://conductscience.org/library/papers/17586306 | PubMed |
| 14 | 21804922 | The neuroblastoma ALK(I1250T) mutation is a kinase-dead RTK in vitro and in vivo. | Transl Oncol | 2011 | https://conductscience.org/library/papers/21804922 | PubMed |
| 15 | 12122009 | Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12122009 | PubMed |
| 16 | 17904822 | In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)? | Cell Signal | 2007 | https://conductscience.org/library/papers/17904822 | PubMed |
| 17 | 9174053 | ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) | Oncogene | 1997 | https://conductscience.org/library/papers/9174053 | PubMed |
| 18 | 15226403 | ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. | J Cell Sci | 2004 | https://conductscience.org/library/papers/15226403 | PubMed |
| 19 | 18923525 | Activating mutations in ALK provide a therapeutic target in neuroblastoma. | Nature | 2008 | https://conductscience.org/library/papers/18923525 | PubMed |
| 20 | 16880530 | Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage. | Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16880530 | PubMed |
Cited by94
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42803850 | ALK ATI in solid tumours: biological evidence, diagnostic challenges, and clinical relevance. a narrative review. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42803850 | PubMed |
| 42616237 | Three decades of anaplastic lymphoma kinase: from physiological roles to cancer and immune evasion. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42616237 | PubMed |
| 41856795 | Alk-Fam150b (augmentor α) expression in the paraventricular nucleus of the mouse hypothalamus at molecular resolution, and its sensitivity to acute stress. | J Neuroendocrinol | 2026 | https://conductscience.org/library/papers/41856795 | PubMed |
| 41798535 | Anaplastic Lymphoma Kinase (ALK)-Positive Large B-cell Lymphoma in Children: A Case Report and Review of Literature. | Cureus | 2026 | https://conductscience.org/library/papers/41798535 | PubMed |
| 41771741 | Ribosomal Profiling of the Geniculate Ganglion Identifies the Receptor ALK as Critical for the Development and Maintenance of Oral Sensory Neurons. | J Neurosci | 2026 | https://conductscience.org/library/papers/41771741 | PubMed |
| 41670693 | Breaking resistance barriers: ensartinib as a milestone in anaplastic lymphoma kinase-driven non-small cell lung cancer therapy. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41670693 | PubMed |
| 40382638 | AlkTango reveals a role for Jeb/Alk signaling in the Drosophila heart. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40382638 | PubMed |
| 40208865 | Reanalysis of cryo-EM data reveals ALK-cytokine assemblies with both 2:1 and 2:2 stoichiometries. | PLoS Biol | 2025 | https://conductscience.org/library/papers/40208865 | PubMed |
| 40055571 | ALK in cancer: from function to therapeutic targeting. | Nat Rev Cancer | 2025 | https://conductscience.org/library/papers/40055571 | PubMed |
| 39138146 | Therapeutic advances of targeting receptor tyrosine kinases in cancer. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39138146 | PubMed |
| 38948020 | Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment. | Oncol Res | 2024 | https://conductscience.org/library/papers/38948020 | PubMed |
| 38927035 | Lysophosphatidic Acid Stimulates Mitogenic Activity and Signaling in Human Neuroblastoma Cells through a Crosstalk with Anaplastic Lymphoma Kinase. | Biomolecules | 2024 | https://conductscience.org/library/papers/38927035 | PubMed |
| 38482965 | Molecular pathological approach to cancer epigenomics and its clinical application. | Pathol Int | 2024 | https://conductscience.org/library/papers/38482965 | PubMed |
| 38424421 | A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements and Mutations: Implications for Gastric Carcinogenesis and Target Therapy. | Curr Protein Pept Sci | 2024 | https://conductscience.org/library/papers/38424421 | PubMed |
| 38397899 | Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions. | Biomedicines | 2024 | https://conductscience.org/library/papers/38397899 | PubMed |
| 38264745 | ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib. | Front Oncol | 2023 | https://conductscience.org/library/papers/38264745 | PubMed |
| 38039964 | ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells. | Cancer Cell | 2023 | https://conductscience.org/library/papers/38039964 | PubMed |
| 37892172 | Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review. | Biomolecules | 2023 | https://conductscience.org/library/papers/37892172 | PubMed |
| 37773318 | ALK fusions in the pan-cancer setting: another tumor-agnostic target? | NPJ Precis Oncol | 2023 | https://conductscience.org/library/papers/37773318 | PubMed |
| 37686528 | IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686528 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALKAL1 | 389658 | Swiss-Prot's references | https://conductscience.org/library/genes/389658 | NCBI Gene |
| ALKAL2 | 285016 | Swiss-Prot's references | https://conductscience.org/library/genes/285016 | NCBI Gene |
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| CSF2RA | 1438 | PubTator's text mining | https://conductscience.org/library/genes/1438 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| EPHB2 | 2048 | PubTator's text mining | https://conductscience.org/library/genes/2048 | NCBI Gene |
| HAL | 3034 | PubTator's text mining | https://conductscience.org/library/genes/3034 | NCBI Gene |
| LTK | 4058 | PubTator's text mining | https://conductscience.org/library/genes/4058 | NCBI Gene |
| RET | 5979 | PubTator's text mining | https://conductscience.org/library/genes/5979 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26418745
GET https://conductscience.org/api/papers/v1/26418745/references?page=2